Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 07/23 06:56:59 pm
92.65 EUR   +0.65%
03:43pBAYER : Young scientists experimenting on health and food science to..
PU
07/20BAYER : to Stop Selling Essure in U.S.
DJ
07/20BAYER : to Stop Selling Essure in U.S.
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies

Ulrich Ebensperger

Financial Analyst
 
share with twitter share with LinkedIn share with facebook
share via e-mail

Still trending down

Strategy published on 07/11/2018 | 09:17
short sell
Live
Entry price : 93.96€ | Target : 88.05€ | Stop-loss : 100€ | Potential : 6.29%
The trend in the price decline should not be put into question for stocks in Bayer over the coming trading sessions given the current chart pattern.
Investors should open a short trade and target the € 88.05.
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • The share is getting closer to its long-term support in weekly data, at EUR 88.91, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • The company is in debt and has limited leeway for investment
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
BAYER-10.06%100 917
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
NOVARTIS-0.24%206 705
ROCHE HOLDING LTD.-5.07%200 737
MERCK AND COMPANY11.11%168 171
AMGEN9.54%126 889
ABBOTT LABORATORIES10.95%111 818
SANOFI0.71%105 544
GLAXOSMITHKLINE17.19%101 446
ELI LILLY AND COMPANY4.75%97 070
NOVO NORDISK A/S-4.11%95 716
ASTRAZENECA9.14%92 447
BRISTOL-MYERS SQUIBB COMPAN..-7.46%92 417
CELGENE CORPORATION-18.46%61 857
ALLERGAN PLC5.02%58 790
More Results
Financials (€)
Sales 2018 39 201 M
EBIT 2018 8 014 M
Net income 2018 5 033 M
Debt 2018 34 233 M
Yield 2018 3,01%
P/E ratio 2018 18,40
P/E ratio 2019 16,31
EV / Sales 2018 3,06x
EV / Sales 2019 2,52x
Capitalization 85 841 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart BAYER
Duration : Period : Day
Bayer Technical Analysis Chart | 4-Traders
Duration : Period : Week
Bayer Technical Analysis Chart | 4-Traders